Expression of perforin in nasal lymphoma: Additional evidence of its natural killer cell derivation

American Journal of Pathology

Volumn 149, Issue 2, 1996, Pages 699-705

  Mori, Naoyoshi ^a   Yatabe, Yasushi ^b   Oka, Kuniyuki ^c   Kinoshita, Tomohiro ^a   Kobayashi, Toshitaka ^d   Ono, Tachio ^e   Asai, Junpei ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c Mito Saiseikai General Hospital   (Japan)

^d University of Tsukuba School of Medicine   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; PERFORIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPHOMA; LYMPHOMA CELL; MALE; NATURAL KILLER CELL; NOSE TUMOR; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, CD3; ANTIGENS, CD56; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL LINEAGE; CYTOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KILLER CELLS, NATURAL; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, MIXED-CELL, DIFFUSE; MALE; MEMBRANE GLYCOPROTEINS; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; NOSE NEOPLASMS; PORE FORMING CYTOTOXIC PROTEINS; RNA, VIRAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030037014     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Ishii Y, Yamanaka N, Ogawa K, Yoshida Y, Takami T, Matsuura A, Isago H, Kataura A, Kikuchi K: Nasal T-cell lymphoma as a type of so-called "lethal midline granuloma". Cancer 1982, 50:2336-2344
2. Chott A, Rappersberger K, Schlossarek W, Radaszkiewicz T Peripheral T cell lymphoma presenting primarily as lethal midline granuloma. Hum Pathol 1988, 19:1093-1101
3. Laeng RH, Gerber HA, Schaffner T, Burki KH: Heterogeneous malignant non-Hodgkin's lymphomas as a causative disorder in lethal midline granuloma. Virchows Arch A Pathol Anat 1989, 415:265-273
4. Ratech H, Burke JS, Blayney DW, Sheibani K, Rappaport H: A clinicopathologic study of malignant lymphomas of the nose, paranasal sinuses. and hard palate, including cases of lethal midline granuloma. Cancer 1989, 64:2525-2531
5. Borisch B, Hennig I, Laeng RH, Waelti ER, Kraft R, Laissue J: Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood 1993, 82:858-864
6. Gaulard P, Henni T, Marolleau J-P, Haioun C, Henni Z, Voisin M-C, Divine M, Goossens M, Farcet J-P, Reyes F: Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis: evidence for a monoclonal T-cell lymphoproliferative disorder. Cancer 1988, 62:705-710
7. Ho FC, Choy D, Loke SL, Kung ITM, Fu KH, Liang R, Todd D, Khoo RKK: Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol 1990, 21:1041-1050
8. Liang R, Todd D, Chan TK, Chiu E, Choy D, Loke SL, Ho FCS: Nasal lymphoma: a retrospective analysis of 60 cases. Cancer 1990, 66:2205-2209
9. Strickler JG, Meneses MF, Habermann TM, Ilstrup DM, Earle JD, McDonald TJ, Chang KL, Weiss LM: Polymorphic reticulosis: a reappraisal. Hum Pathol 1994, 25: 659-665
10. Chan JKC, Lau WH, Lo STH: Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 1987, 11:418-429
11. Ng CS, Chan JKC, Lo STM: Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum Pathol 1987, 18:1257-1262
12. Kanavaros P, Lescs M-C, Briere J, Divine M, Galateau F, Joab I, Bosq J, Farcet J-P, Reyes F, Gaulaud P: Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993, 81:2688-2695
13. Yamaguchi M, Ohno T, Oka K, Nishii K, Kawakami K, Miwa H, Kita K, Shirakawa S: Discordant reaction of Leu4 and rabbit anti-human CD3∈ in sinonasal T-cell lymphoma. Int J Hematol 1993, 59:25-30
14. Suzumiya J, Takeshita M, Kimura N, Kikuchi M, Uchida T, Hisano S, Eura Y, Kozuru M, Nomura Y, Tomita K, Komiyama S, Okumura M: Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood 1994, 83:2255-2260
15. Aozasa K, Ohsawa M, Tajima K, Sasaki R, Maeda H, Matsunaga T, Friedmann I: Nation-wide study of lethal mid-line granuloma in Japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma, and other related conditions, Int J Cancer 1989, 44:63-66
16. Mishima K, Horiuchi K, Kojya S, Takahashi H, Ohsawa M, Aozasa K: Epstein-Barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from China and Japan. Cancer 1994, 73:3041-3046
17. Arber DA, Weiss LM, Albujar PF, Chen Y-Y, Jaffe ES: Nasal lymphomas in Peru: high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 1993, 17:392-399
18. Wong KF, Chan JKC, Ng CS, Tsang WYW, Cheung MMC: CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum Pathol 1992, 23:798-804
19. Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM: Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992, 79:2432-2437
20. Nakamura S, Suchi T, Koshikawa T, Kitoh K, Koike K, Komatsu H, Iida S, Kagami Y, Ogura M, Katoh E, Kurita S, Suzuki H, Kobashi Y, Yamabe H, Hirabayashi N, Ueda R, Takahashi T: Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995, 19:284-296
21. Harabuchi Y, Yamanishi N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T: Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990, 335:128-130
22. Tao Q, Ho FCS, Loke SL, Srivastava G: Epstein-Barr virus is localized in the tumor cells of nasal lymphomas of NK, T, or B cell type, Int J Cancer 1995, 60:315-320
23. Young JDE, Hengartner H, Podack ER, Cohn ZA: Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity Cell 1986, 44:849-859
24. Martin AR, Chan WC, Perry DA, Greiner TC, Weisenburger DD: Aggressive natural killer cell lymphoma of the small intestine. Mod Pathol 1995, 8:467-472
25. Taylor CR: An immunohistological study of follicular lymphoma, reticulum cell sarcoma, and Hodgkin's disease. Eur J Cancer 1976, 12:61-75
26. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981, 29:577-580
27. Mclean IW, Nakane PK: Periodate-lysine-paraformaldehyde fixative: a new fixative for immunoelectron microscopy. J Histochem Cytochem 1974, 22:1077-1083
28. Tsunoda R, Terashima K, Takahashi K, Kojima M: An ultrastructural study with enzyme-labeled antibody technique on immunoglobulin containing cells in human tonsils, especially in germinal centers. Acta Pathol Jpn 1978, 28:53-75
29. Wu T-C, Mann RB, Epstein JI, McMahon E, Lee WA, Charache P, Hayward SD, Kurman RJ, Hayward GS, Ambinder RF: Abundant expression of EBER-1 small nuclear RNA in nasopharyngeal carcinoma: a morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed, paraffin-embedded carcinoma specimens. Am J Pathol 1991, 138:1461-1469
30. Chang KL, Chen YY, Shibata D, Weiss LM: Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol 1992, 1:246-255
31. Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van Krieken JHJM, Pallesen G: Epstein-Barr virus latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma: correlation of lymphoma phenotype with three distinct patterns of viral latency. Am J Pathol 1993, 143:1072-1085
32. Tokunaga M, Imai S, Uemura Y, Tokudome T, Osato T, Sato E: Epstein-Barr virus in adult T-cell leukemia/lymphoma. Am J Pathol 1993, 143:1263-1269
33. Griffiths GM, Mueller C: Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells, Immunol Today 1991, 12:415-419
34. Fox WM III, Hameed A, Hutchins GM, Reitz BA, Baumgartner WA, Beschorner WE, Hruban RH: Perforin expression localizing cytotoxic lymphocytes in the intimas of coronary arteries with transplant-related accelerated arteriosclerosis. Hum Pathol 1993, 24: 477-482
35. Takeuchi Y, Nishimura T, Gao XH, Watanabe K, Akatsuka A, Shinkai Y, Okumura K, Habu S: Perforin is expressed in CTL populations generated in vivo, Immunol Lett 1992, 31:183-187
36. Chan JKC, Tsang WYW, Ng CS, Pau MY: Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections. Hum Pathol 1995, 26:1139-1143
37. Ohno T, Yamaguchi M, Oka K, Miwa H, Kita K, Shirakawa S: Frequent expression of CD3∈ in CD3 (Leu4)-negative nasal T-cell lymphomas. Leukemia 1995, 9:44-52
38. Lanier LL, Chang C, Spitz H, Phillips JH: Expression of cytoplasmic CD3∈ proteins in activated human adult natural killer cells (NK cells) and CD3γ, δ, ∈ complexes in fetal NK cells. J Immunol 1992, 149: 1876-1880
39. Phillips JH, Hori T, Nagler A, Bhat N, Spitz H, Lanier LL: Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3∈, δ proteins. J Exp Med 1992, 175: 1055-1066
40. Lanier LL, Spitz H, Phillips JH: The developmental relationship between NK cells and T cells, Immunol Today 1992, 13:392-395
41. + cells neoplastic or reactive? Blood 1995, 85:2993-2994